Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meztli Ramos-García has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gut Microbiota Composition in Rats Consuming Sucralose or Rebaudioside A at Recommended Doses Under Two Dietary Interventions

    by Meztli Ramos-García, Alma Delia Genis-Mendoza, Carlos García-Vázquez, José Jaime Martínez-Magaña, Viridiana Olvera-Hernández, Mirian Carolina Martínez-López, Juan Cuauhtémoc Díaz-Zagoya, Carina Shianya Alvarez-Villagomez, Isela Esther Juárez-Rojop, Humberto Nicolini, et al.

    Background: Artificial non-nutritive sweeteners (NNSs), such as sucralose, have been associated with gut microbiota (GM) alterations. However, the impact of rebaudioside A (reb A), a natural NNS, on GM has received limited scrutiny. Objective: The objective of this study was to examine the response of GM composition to sucralose and reb A in rats under two dietary conditions. Methods: Male Wistar rats (150–200 g) fed with a normal diet (ND) or a high-fat diet (HFD) were randomly assigned to receive sucralose (SCL), reb A (REB), glucose (GLU, control), or sucrose (SUC). The NNS interventions were administered in water at doses equivalent to the acceptable daily intake (ADI). After eight weeks, the GM composition in fecal samples was analyzed through 16S ribosomal RNA gene sequencing. Results: The NNSs did not modify the diversity, structure, phylum-level composition, or Firmicutes/Bacteroidetes (F/B) ratio of the GM in rats under ND or HFD. However, REB with HFD decreased Bacilli and increased Faecalibacterium abundance at the class level. SCL and REB in rats receiving ND reduced the genera Romboutsia and Lactobacillus. Conclusions: Our study suggests that when sucralose or reb A is consumed at recommended doses, there is no alteration in the diversity or the composition of the GM at the phylum level. The clinical relevance of these findings lies in the potential modifications of the GM at specific taxonomic levels by the consumption of these NNSs. Further research involving humans and including a broader range of microbial analyses is warranted.


  • Open Access

    Effects of Sucralose Supplementation on Glycemic Response, Appetite, and Gut Microbiota in Subjects with Overweight or Obesity: A Randomized Crossover Study Protocol

    by Zeniff Reyes-López, Viridiana Olvera-Hernández, Meztli Ramos-García, José D. Méndez, Crystell G. Guzmán-Priego, Miriam C. Martínez-López, Carlos García-Vázquez, Carina S. Alvarez-Villagomez, Isela E. Juárez-Rojop, Juan C. Díaz-Zagoya, et al.

    Sucralose stands as the most common non-nutritive sweetener; however, its metabolic effects have sparked significant controversy over the years. We aim to examine the effects of sucralose daily intake on glycemia, subjective appetite, and gut microbiota (GM) changes in subjects with overweight or obesity. In this randomized, crossover, and controlled trial, 23 participants with a body mass index between 25 kg/m2 and 39.9 kg/m2 will be assigned to one of two interventions to receive either sucralose (2 mg/kg/day equivalent to 40% of the acceptable daily intake) or glucose (control) for 4 weeks, each phase separated by a 4-week washout period. The glycemic response will be determined during a meal tolerance test, subjective appetite will be evaluated using a visual analog scale, and GM changes will be analyzed by next-generation sequencing of the bacterial rRNA 16S gene from fecal samples. All measures will be performed before and after intervention periods. We hypothesize that sucralose supplementation induces changes in glycemic response, subjective appetite, and gut microbiota in overweight and obese participants. This protocol was approved by the Ethics Committee of the UJAT (No. 0721) and was registered in the Australian New Zealand Clinical Trials Registry (ACTRN12621001531808).


  • Open Access

    Effect of Early Time-Restricted Eating on Metabolic Markers and Body Composition in Individuals with Overweight or Obesity

    by Dalila Rubí Mena-Hernández, Guadalupe Jiménez-Domínguez, José D. Méndez, Viridiana Olvera-Hernández, Mirian C. Martínez-López, Crystell G. Guzmán-Priego, Zeniff Reyes-López, Meztli Ramos-García, Isela E. Juárez-Rojop, Selene S. Zavaleta-Toledo, et al.

    This study aimed to evaluate the effect of early time-restricted eating (eTRE) on metabolic markers and body composition in individuals with overweight or obesity. Seventeen subjects completed a randomized, crossover, and controlled clinical trial. Twelve women and five men participated, with a mean age of 25.8 ± 10.0 years and a BMI of 32.0 ± 6.3 kg/m2. The eTRE intervention included 16 h of fasting (3:00 pm to 7:00 am) and 8 h of ad libitum eating (7:00 am to 03:00 pm) (16:8). The trial included four weeks of interventions followed by a four-week washout period. Body weight, waist and hip circumferences, and body composition measurements were taken. Additionally, a venous blood sample was collected for biochemical determinations. In a before–after analysis, eTRE induced a reduction in BW and BMI in women but this was not significant when compared to the control group. eTRE did not modify any other anthropometric measurements, fasting biochemical parameters, glycemic and insulinemic responses, blood pressure, or subjective appetite. In conclusion, eTRE did not induce beneficial effects on the glycemic and lipid metabolisms, body composition, subjective appetite, or blood pressure. These findings may be attributed to the special characteristics of the population and the short intervention period.


  • Open Access

    Sucralose or rebaudioside A at recommended doses did not alter the gut microbiota composition in rats under two dietary conditions

    by Meztli Ramos-García, Alma Delia Genis-Mendoza, Carlos García-Vázquez, José Jaime Martínez-Magaña, Viridiana Olvera-Hernández, Mirian Carolina Martínez-López, Juan Cuauhtémoc Díaz-Zagoya, Carina Shianya Alvarez-Villagomez, Isela Esther Juárez-Rojop, Humberto Nicolini, et al.

    Research reported that non-nutritive sweeteners (NNS), including sucralose, elicit metabolic changes through the gut microbiota (GM) modulation, nonetheless, this topic remains controversial. Furthermore, the impact of rebaudioside A (reb A) on GM has received limited scrutiny. Consequently, we aim to investigate the response of GM composition to both sucralose and reb A in rats, considering two distinct dietary conditions. Male Wistar rats (150–200 g) fed either a normal diet (ND) or a high-fat diet (HFD) were randomly assigned to receive sucralose (SCL), reb A (REB), glucose (GLU, control), or sucrose (SUC). The NNS were administered in water at doses equivalent to the human acceptable daily intake (ADI). Following eight weeks, the GM composition in fecal samples was analyzed through 16S ribosomal RNA gene sequencing. The NNS did not modify the diversity, the structure, the composition at the phylum level, and the Firmicutes/Bacteroidetes (F/B) ratio of the GM. At the class level, REB with HFD decreased Bacilli and increased Faecalibacterium abundance. SCL and REB in combination with ND reduced the genera Romboutsia and Lactobacillus. On the other hand, the analysis of the effect of the diet without NNS showed that HFD increased the proportions of Bacilli and Coriobacteriia, despite not observing changes in the F/B ratio. Our study indicates that when sucralose or reb A is consumed at recommended doses, there is no observed alteration in the diversity and composition of the GM at the phylum level. Consequently, our data suggest that these NNS do not substantially impact the GM. We encourage further research to delve into the potential modifications of the GM at the level of specific bacterial taxa, as this could offer valuable insights for clinical interventions.

  • Eficacia y seguridad de la administración de plasma de convaleciente en pacientes con COVID-19

    by Priscila Edith Escobedo-Sánchez, Ibis de la Cruz-Hernández, Meztli Ramos-García, Iván Sánchez-Yedra, Carlos García-Vázquez, Crystell Guadalupe Guzmán-Priego, María Victoria García-Vidrios, Viridiana Olvera-Hernández, Yolanda Mendoza-García, Jorge Luis Ble-Castillo


  • Effects of resistant starch on glycemic response, postprandial lipemia and appetite in subjects with type 2 diabetes

    by Carlos García-Vázquez, Jorge L. Ble-Castillo, Yolanda Arias-Córdova, Meztli Ramos-García, Viridiana Olvera-Hernández, Crystell G. Guzmán-Priego, Mirian C. Martínez-López, Guadalupe Jiménez-Domínguez, Josafat A. Hernández-Becerra

    Purpose Resistant starch (RS) content has exhibited beneficial effects on glycemic control; however, few studies have investigated the effects of this substance on postprandial responses and appetite in subjects with type 2 diabetes (T2D). Here, we aimed to examine the effects of RS from two sources on glycemic response (GR), postprandial lipemia, and appetite in subjects with T2D. Methods In a randomized and crossover study, 17 subjects with T2D consumed native banana starch (NBS), high-amylose maize starch (HMS) or digestible maize starch (DMS) for 4 days. On day 5, a 6-h oral meal tolerance test (MTT) was performed to evaluate glycemic and insulinemic responses as well as postprandial lipemia. Besides, subjective appetite assessment was measured using a visual analogue scale. Results NBS induced a reduction on fasting glycemia, glycemia peak and insulinemic response during MTT. However, no modifications on postprandial lipemia were observed after RS treatments. Both NBS and HMS reduced hunger and increased satiety. Conclusion NBS supplementation induced more beneficial effects on glycemic metabolism than HMS even when all interventions were matched for digestible starch content. RS intake did not modify postprandial lipemia, however, positively affected subjective appetite rates. Trial registration: This trial was retrospectively registered at www.anzctr.org.au (ACTRN12621001382864) on October 11, 2021.


  • Open Access

    Resistant Starch Consumption Effects on Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes: A Randomized Crossover Study

    by Yolanda Arias-Córdova, Jorge Luis Ble-Castillo, Carlos García-Vázquez, Viridiana Olvera-Hernández, Meztli Ramos-García, Adrián Navarrete-Cortes, Guadalupe Jiménez-Domínguez, Isela Esther Juárez-Rojop, Carlos Alfonso Tovilla-Zárate, Mirian Carolina Martínez-López, et al.

    We previously observed beneficial effects of native banana starch (NBS) with a high resistant starch (RS) content on glycemic response in lean and obese participants. Here, we aimed to determine the effects of NBS and high-amylose maize starch (HMS) on glycemic control (GC) and glycemic variability (GV) in patients with type 2 diabetes (T2D) when treatments were matched for digestible starch content. In a randomized, crossover study, continuous glucose monitoring (CGM) was performed in 17 participants (aged 28–65 years, BMI ≥ 25 kg/m2, both genders) consuming HMS, NBS, or digestible maize starch (DMS) for 4 days. HMS and NBS induced an increase in 24 h mean blood glucose during days 2 to 4 (p < 0.05). CONGA, GRADE, and J-index values were higher in HMS compared with DMS only at day 4 (p < 0.05). Yet, NBS intake provoked a reduction in fasting glycemia changes from baseline compared with DMS (p = 0.0074). In conclusion, under the experimental conditions, RS from two sources did not improve GC or GV. Future longer studies are needed to determine whether these findings were affected by a different baseline microbiota or other environmental factors.


  • Open Access

    Effects of Non-Nutritive Sweeteners on Energy Intake, Body Weight and Postprandial Glycemia in Healthy and with Altered Glycemic Response Rats

    by Meztli Ramos-García, Jorge Luis Ble-Castillo, Carlos García-Vázquez, Carlos Alfonso Tovilla-Zárate, Isela Esther Juárez-Rojop, Viridiana Olvera-Hernández, Alma Delia Genis-Mendoza, Rubén Córdova-Uscanga, Carlos Alfonso Álvarez-González, Juan Cuauhtémoc Díaz-Zagoya

    The aim of this study was to evaluate the effects of non-nutritive sweeteners (NNS) consumption on energy intake, body weight and postprandial glycemia in healthy and with altered glycemic response rats. Animals on normal diet (ND) or high-fat diet (HFD) were divided to receive NNS (sucralose, aspartame, stevia, rebaudioside A) or nutritive sweeteners (glucose, sucrose) for 8 weeks. The NNS were administered at doses equivalent to the human acceptable daily intake (ADI). A test using rapidly digestible starch was performed before and after treatments to estimate glycemic response. No effects of NNS consumption were observed on energy intake or body weight. Sucrose provoked an increased fluid consumption, however, energy intake, and weight gain were not altered. In ND, no effects of NNS on glycemic response were observed. In HFD, the glycemic response was increased after sucralose and stevia when only the final tolerance test was considered, however, after including the baseline test, these results were no longer significant compared to glucose. These findings provide further evidence suggesting that at the recommended doses, NNS do not alter feeding behavior, body weight or glycemic tolerance in healthy and with altered glycemic rats.